Hormonal Contraception Market Insights, SWOT Analysis and Future Growth trend by Players – Bayer AG, Merck & Co., Inc., Pfizer, Inc., Agile Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Amgen, Cipla Ltd., Glenmark Pharmaceuticals Inc., Lupin Limited(Lupin Pharmaceuticals, Inc.), Novartis AG, Mylan N.V., Johnson & Johnson, Ansell LTD, Mayer Laboratories, Inc.

 Hormonal Contraception  Market Research Report

LOS ANGELES, United States: QY Research has recently published a market research report titled, “Global Hormonal Contraception Sales Market Report 2021“. Analysts have used primary and secondary research methodologies to determine the path of the market. The data includes historic and forecast values for a well-rounded understanding. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Hormonal Contraception market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Hormonal Contraception market.

TThis report includes assessment of various drivers, government policies, technological innovations, upcoming technologies, opportunities, market risks, restrains, market barriers, challenges, trends, competitive landscape, and segments which gives an exact picture of the growth of the global Hormonal Contraception market.

Top Companies/Manufacturers:
, Bayer AG, Merck & Co., Inc., Pfizer, Inc., Agile Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Amgen, Cipla Ltd., Glenmark Pharmaceuticals Inc., Lupin Limited(Lupin Pharmaceuticals, Inc.), Novartis AG, Mylan N.V., Johnson & Johnson, Ansell LTD, Mayer Laboratories, Inc.
Market Segment by Product Type: by Hormone, , Androgens, , Estrogens, , Progestrogens, , Antiandrogens, , Gonadotropins, by Method, , Combined Oral, , Oral Pill, , Implanted, , Injected, , Intrauterine, , Transdermal Patch
Market Segment by Application: Hospital, Clinics, Gynaecology Centers, Others



Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Hormonal Contraception market.

Key questions answered in the report:

  • What is the growth potential of the Hormonal Contraception market?
  • Which product segment will grab a lion’s share?
  • Which regional market will emerge as a frontrunner in the coming years?
  • Which application segment will grow at a robust rate?
  • What are the growth opportunities that may emerge in the Hormonal Contraception industry in the years to come?
  • What are the key challenges that the global Hormonal Contraception market may face in the future?
  • Which are the leading companies in the global Hormonal Contraception market?
  • Which are the key trends positively impacting the market growth?
  • Which are the growth strategies considered by the players to sustain hold in the global Hormonal Contraception market

TOC

1 Hormonal Contraception Market Overview
1.1 Hormonal Contraception Product Scope
1.2 Hormonal Contraception Segment by Type
1.2.1 Global Hormonal Contraception Sales by Type (2016 & 2021 & 2027)
1.2.2 Androgens
1.2.3 Estrogens
1.2.4 Progestrogens
1.2.5 Antiandrogens
1.2.6 Gonadotropins
1.3 Hormonal Contraception Segment by Application
1.3.1 Global Hormonal Contraception Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Gynaecology Centers
1.3.5 Others
1.4 Hormonal Contraception Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hormonal Contraception Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hormonal Contraception Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hormonal Contraception Price Trends (2016-2027) 2 Hormonal Contraception Estimates and Forecasts by Region
2.1 Global Hormonal Contraception Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hormonal Contraception Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hormonal Contraception Sales Market Share by Region (2016-2021)
2.2.2 Global Hormonal Contraception Revenue Market Share by Region (2016-2021)
2.3 Global Hormonal Contraception Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hormonal Contraception Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hormonal Contraception Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hormonal Contraception Estimates and Projections (2016-2027)
2.4.2 Europe Hormonal Contraception Estimates and Projections (2016-2027)
2.4.3 China Hormonal Contraception Estimates and Projections (2016-2027)
2.4.4 Japan Hormonal Contraception Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hormonal Contraception Estimates and Projections (2016-2027)
2.4.6 India Hormonal Contraception Estimates and Projections (2016-2027) 3 Global Hormonal Contraception Competition Landscape by Players
3.1 Global Top Hormonal Contraception Players by Sales (2016-2021)
3.2 Global Top Hormonal Contraception Players by Revenue (2016-2021)
3.3 Global Hormonal Contraception Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hormonal Contraception as of 2020)
3.4 Global Hormonal Contraception Average Price by Company (2016-2021)
3.5 Manufacturers Hormonal Contraception Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Hormonal Contraception Market Size by Type
4.1 Global Hormonal Contraception Historic Market Review by Type (2016-2021)
4.1.1 Global Hormonal Contraception Sales Market Share by Type (2016-2021)
4.1.2 Global Hormonal Contraception Revenue Market Share by Type (2016-2021)
4.1.3 Global Hormonal Contraception Price by Type (2016-2021)
4.2 Global Hormonal Contraception Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hormonal Contraception Sales Forecast by Type (2022-2027)
4.2.2 Global Hormonal Contraception Revenue Forecast by Type (2022-2027)
4.2.3 Global Hormonal Contraception Price Forecast by Type (2022-2027) 5 Global Hormonal Contraception Market Size by Application
5.1 Global Hormonal Contraception Historic Market Review by Application (2016-2021)
5.1.1 Global Hormonal Contraception Sales Market Share by Application (2016-2021)
5.1.2 Global Hormonal Contraception Revenue Market Share by Application (2016-2021)
5.1.3 Global Hormonal Contraception Price by Application (2016-2021)
5.2 Global Hormonal Contraception Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hormonal Contraception Sales Forecast by Application (2022-2027)
5.2.2 Global Hormonal Contraception Revenue Forecast by Application (2022-2027)
5.2.3 Global Hormonal Contraception Price Forecast by Application (2022-2027) 6 North America Hormonal Contraception Market Facts & Figures
6.1 North America Hormonal Contraception Sales by Company
6.1.1 North America Hormonal Contraception Sales by Company (2016-2021)
6.1.2 North America Hormonal Contraception Revenue by Company (2016-2021)
6.2 North America Hormonal Contraception Sales Breakdown by Type
6.2.1 North America Hormonal Contraception Sales Breakdown by Type (2016-2021)
6.2.2 North America Hormonal Contraception Sales Breakdown by Type (2022-2027)
6.3 North America Hormonal Contraception Sales Breakdown by Application
6.3.1 North America Hormonal Contraception Sales Breakdown by Application (2016-2021)
6.3.2 North America Hormonal Contraception Sales Breakdown by Application (2022-2027) 7 Europe Hormonal Contraception Market Facts & Figures
7.1 Europe Hormonal Contraception Sales by Company
7.1.1 Europe Hormonal Contraception Sales by Company (2016-2021)
7.1.2 Europe Hormonal Contraception Revenue by Company (2016-2021)
7.2 Europe Hormonal Contraception Sales Breakdown by Type
7.2.1 Europe Hormonal Contraception Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hormonal Contraception Sales Breakdown by Type (2022-2027)
7.3 Europe Hormonal Contraception Sales Breakdown by Application
7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 140 Sales Breakdown by Application (2022-2027) 8 China Hormonal Contraception Market Facts & Figures
8.1 China Hormonal Contraception Sales by Company
8.1.1 China Hormonal Contraception Sales by Company (2016-2021)
8.1.2 China Hormonal Contraception Revenue by Company (2016-2021)
8.2 China Hormonal Contraception Sales Breakdown by Type
8.2.1 China Hormonal Contraception Sales Breakdown by Type (2016-2021)
8.2.2 China Hormonal Contraception Sales Breakdown by Type (2022-2027)
8.3 China Hormonal Contraception Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027) 9 Japan Hormonal Contraception Market Facts & Figures
9.1 Japan Hormonal Contraception Sales by Company
9.1.1 Japan Hormonal Contraception Sales by Company (2016-2021)
9.1.2 Japan Hormonal Contraception Revenue by Company (2016-2021)
9.2 Japan Hormonal Contraception Sales Breakdown by Type
9.2.1 Japan Hormonal Contraception Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hormonal Contraception Sales Breakdown by Type (2022-2027)
9.3 Japan Hormonal Contraception Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Hormonal Contraception Market Facts & Figures
10.1 Southeast Asia Hormonal Contraception Sales by Company
10.1.1 Southeast Asia Hormonal Contraception Sales by Company (2016-2021)
10.1.2 Southeast Asia Hormonal Contraception Revenue by Company (2016-2021)
10.2 Southeast Asia Hormonal Contraception Sales Breakdown by Type
10.2.1 Southeast Asia Hormonal Contraception Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hormonal Contraception Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hormonal Contraception Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Hormonal Contraception Market Facts & Figures
11.1 India Hormonal Contraception Sales by Company
11.1.1 India Hormonal Contraception Sales by Company (2016-2021)
11.1.2 India Hormonal Contraception Revenue by Company (2016-2021)
11.2 India Hormonal Contraception Sales Breakdown by Type
11.2.1 India Hormonal Contraception Sales Breakdown by Type (2016-2021)
11.2.2 India Hormonal Contraception Sales Breakdown by Type (2022-2027)
11.3 India Hormonal Contraception Sales Breakdown by Application
11.3.1 India Hormonal Contraception Sales Breakdown by Application (2016-2021)
11.3.2 India Hormonal Contraception Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Hormonal Contraception Business
12.1 Bayer AG
12.1.1 Bayer AG Corporation Information
12.1.2 Bayer AG Business Overview
12.1.3 Bayer AG Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer AG Hormonal Contraception Products Offered
12.1.5 Bayer AG Recent Development
12.2 Merck & Co., Inc.
12.2.1 Merck & Co., Inc. Corporation Information
12.2.2 Merck & Co., Inc. Business Overview
12.2.3 Merck & Co., Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck & Co., Inc. Hormonal Contraception Products Offered
12.2.5 Merck & Co., Inc. Recent Development
12.3 Pfizer, Inc.
12.3.1 Pfizer, Inc. Corporation Information
12.3.2 Pfizer, Inc. Business Overview
12.3.3 Pfizer, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer, Inc. Hormonal Contraception Products Offered
12.3.5 Pfizer, Inc. Recent Development
12.4 Agile Therapeutics, Inc.
12.4.1 Agile Therapeutics, Inc. Corporation Information
12.4.2 Agile Therapeutics, Inc. Business Overview
12.4.3 Agile Therapeutics, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Agile Therapeutics, Inc. Hormonal Contraception Products Offered
12.4.5 Agile Therapeutics, Inc. Recent Development
12.5 Teva Pharmaceutical Industries Ltd.
12.5.1 Teva Pharmaceutical Industries Ltd. Corporation Information
12.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
12.5.3 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Products Offered
12.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.6 Amgen
12.6.1 Amgen Corporation Information
12.6.2 Amgen Business Overview
12.6.3 Amgen Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Amgen Hormonal Contraception Products Offered
12.6.5 Amgen Recent Development
12.7 Cipla Ltd.
12.7.1 Cipla Ltd. Corporation Information
12.7.2 Cipla Ltd. Business Overview
12.7.3 Cipla Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cipla Ltd. Hormonal Contraception Products Offered
12.7.5 Cipla Ltd. Recent Development
12.8 Glenmark Pharmaceuticals Inc.
12.8.1 Glenmark Pharmaceuticals Inc. Corporation Information
12.8.2 Glenmark Pharmaceuticals Inc. Business Overview
12.8.3 Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Glenmark Pharmaceuticals Inc. Hormonal Contraception Products Offered
12.8.5 Glenmark Pharmaceuticals Inc. Recent Development
12.9 Lupin Limited(Lupin Pharmaceuticals, Inc.)
12.9.1 Lupin Limited(Lupin Pharmaceuticals, Inc.) Corporation Information
12.9.2 Lupin Limited(Lupin Pharmaceuticals, Inc.) Business Overview
12.9.3 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Products Offered
12.9.5 Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Development
12.10 Novartis AG
12.10.1 Novartis AG Corporation Information
12.10.2 Novartis AG Business Overview
12.10.3 Novartis AG Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis AG Hormonal Contraception Products Offered
12.10.5 Novartis AG Recent Development
12.11 Mylan N.V.
12.11.1 Mylan N.V. Corporation Information
12.11.2 Mylan N.V. Business Overview
12.11.3 Mylan N.V. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Mylan N.V. Hormonal Contraception Products Offered
12.11.5 Mylan N.V. Recent Development
12.12 Johnson & Johnson
12.12.1 Johnson & Johnson Corporation Information
12.12.2 Johnson & Johnson Business Overview
12.12.3 Johnson & Johnson Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Johnson & Johnson Hormonal Contraception Products Offered
12.12.5 Johnson & Johnson Recent Development
12.13 Ansell LTD
12.13.1 Ansell LTD Corporation Information
12.13.2 Ansell LTD Business Overview
12.13.3 Ansell LTD Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Ansell LTD Hormonal Contraception Products Offered
12.13.5 Ansell LTD Recent Development
12.14 Mayer Laboratories, Inc.
12.14.1 Mayer Laboratories, Inc. Corporation Information
12.14.2 Mayer Laboratories, Inc. Business Overview
12.14.3 Mayer Laboratories, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Mayer Laboratories, Inc. Hormonal Contraception Products Offered
12.14.5 Mayer Laboratories, Inc. Recent Development 13 Hormonal Contraception Manufacturing Cost Analysis
13.1 Hormonal Contraception Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hormonal Contraception
13.4 Hormonal Contraception Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hormonal Contraception Distributors List
14.3 Hormonal Contraception Customers 15 Market Dynamics
15.1 Hormonal Contraception Market Trends
15.2 Hormonal Contraception Drivers
15.3 Hormonal Contraception Market Challenges
15.4 Hormonal Contraception Market Restraints 16 Research Findings and Conclusion 17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.